|
Name: SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole
Type: Synthetic cannabinoid
AKA: SR-19 and RCS-4
![SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole image](https://grammasearch.com/dev/v2/img/syntheticcannabis.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
![SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) image](/dev/v2/pages/pubchem_images/12477950.png)
|
|
IV. History
SR-19, a synthetic cannabinoid, was first synthesized in the early 2010s as part of research into cannabinoid receptor ligands. It was developed to mimic the effects of THC, the active component of cannabis. SR-19 found its way into synthetic cannabis products, leading to its widespread recreational use. Due to its potent psychoactive effects and potential health risks, SR-19 has been banned in many countries. Its history illustrates the challenges of regulating synthetic cannabinoids and addressing their impact on public health.
|
|
V. Legal Information
SR-19, a synthetic cannabinoid, is often regulated under analog laws due to its psychoactive effects. In the US, it might fall under the Federal Analog Act if deemed similar to other controlled substances. Globally, its status reflects efforts to manage novel psychoactive substances.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
SR-19, a synthetic cannabinoid, produces potent psychoactive effects. As an upper, it induces euphoria and altered perception. Short-term effects include heightened sensory experiences, while long-term use can lead to psychological issues. Overdose risks include severe agitation and cardiovascular problems. Safe use involves cautious dosing, and recent research highlights its high potency and potential for misuse.  |
|
VII. Psychological Effects
SR-19, a synthetic cannabinoid, affects cannabinoid receptors, leading to altered perception and mood. Immediate effects include euphoria and relaxation, while long-term use may result in anxiety and cognitive impairments. Research focuses on its potency, safety, and psychological impact.
 |
|
VIII. Culture
SR-19 is a synthetic cannabinoid mimicking THC effects, classifying it as a downer. Short-term use induces euphoria, relaxation, and altered perception, while long-term use may lead to cognitive impairment and psychological dependence. Overdose can result in severe anxiety, hallucinations, and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research highlights its abuse potential and health risks. Physical signs include red eyes, dry mouth, and altered mental state.
 |